Practical considerations for treating patients with cancer in the COVID-19 pandemic

Date

2020

Authors

Segelov, Eva
Underhill, Craig
Prenen, Hans
Karapetis, C S
Jackson, Christopher
Nott, Louise M
Clay, Tim
Pavlakis, Nick
Sabesan, Sabe
Heywood, Ellen

Journal Title

Journal ISSN

Volume Title

Publisher

Lippincott Williams & Wilkins Ltd.

Abstract

Cancer has become a prevalent disease, affecting millions of new patients globally each year. The COVID-19 pandemic is having far-reaching impacts around the world, causing substantial disruptions to health and health care systems that are likely to last for a prolonged period. Early data have suggested that having cancer is a significant risk factor for mortality from severe COVID-19. A diverse group of medical oncologists met to formulate detailed practical advice on systemic anticancer treatments during this crisis. In the context of broad principles, issues including risks of treatment, principles of prioritizing resources, treatment of elderly patients, and psychosocial impact are discussed. Detailed treatment advice and options are given at a tumor stream level. We must maintain care for patients with cancer as best we can and recognize that COVID-19 poses a significant competing risk for death that changes conventional treatment paradigms.

Description

Keywords

Citation

Source

American Journal of Clinical Oncology

Type

Journal article

Book Title

Entity type

Access Statement

License Rights

Restricted until

2099-12-31

Downloads

Back to topicon-arrow-up-solid
 
APRU
IARU
 
edX
Group of Eight Member

Acknowledgement of Country

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.


Contact ANUCopyrightDisclaimerPrivacyFreedom of Information

+61 2 6125 5111 The Australian National University, Canberra

TEQSA Provider ID: PRV12002 (Australian University) CRICOS Provider Code: 00120C ABN: 52 234 063 906